Prostate Cancer Screening Recommended Only for High-Risk Men with BRCA2 Gene Variant
L'essentiel
UK's National Screening Committee recommends prostate cancer screening via PSA blood test only for men with BRCA2 gene variant and family history of specific cancers, citing harms outweighing benefits in other groups.
Résumé généré par IA
UK's National Screening Committee recommends prostate cancer screening via PSA blood test only for men with BRCA2 gene variant and family history of specific cancers, citing harms outweighing benefits in other groups.





